APO Research
Talk to an analyst

APO RESEARCH · REPORT

Devic's Disease Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Devic's Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025199 pages

Choose your research edition.

Industry ResearchDevic's Disease Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Devic's Disease Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Devic's Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Devic's Disease Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Devic's Disease Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Devic's Disease Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Devic's Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Devic's Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Devic's Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Devic's Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Devic's Disease Drug include CBOP, CSL, Fresenius, Grifols, Gyjtrs, Intas, Nang Kuang, Octapharma and Tianjin Kingyork, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Devic's Disease Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Devic's Disease Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Devic's Disease Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Devic's Disease Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Devic's Disease Drug Segment by Company

CBOP

CSL

Fresenius

Grifols

Gyjtrs

Intas

Nang Kuang

Octapharma

Tianjin Kingyork

Baxter

Pfizer

Sandoz

TEVA

Devic's Disease Drug Segment by Type

Glucocorticoids

Immunoglobulin

Other

Devic's Disease Drug Segment by Application

Hospitals

Clinics

Others

Devic's Disease Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Devic's Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Devic's Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Devic's Disease Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Devic's Disease Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Devic's Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Devic's Disease Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Devic's Disease Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Devic's Disease Drug Industry Trends Table 2. Devic's Disease Drug Industry Drivers Table 3. Devic's Disease Drug Industry Opportunities and Challenges Table 4. Devic's Disease Drug Industry Restraints Table 5. Global Devic's Disease Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Devic's Disease Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Devic's Disease Drug Sales by Manufacturers (K Tons) & (2021-2026) Table 8. Global Devic's Disease Drug Sales Market Share by Manufacturers Table 9. Global Devic's Disease Drug Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Devic's Disease Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Devic's Disease Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Devic's Disease Drug Manufacturers, Product Type & Application Table 13. Global Devic's Disease Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Devic's Disease Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Glucocorticoids Table 17. Major Manufacturers of Immunoglobulin Table 18. Major Manufacturers of Other Table 19. Global Devic's Disease Drug Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 20. Global Devic's Disease Drug Sales by Type (2021-2026) & (K Tons) Table 21. Global Devic's Disease Drug Sales by Type (2027-2032) & (K Tons) Table 22. Global Devic's Disease Drug Sales Market Share by Type (2021-2026) Table 23. Global Devic's Disease Drug Sales Market Share by Type (2027-2032) Table 24. Global Devic's Disease Drug Revenue by Type 2021 VS 2025 VS 2032 (K Tons) Table 25. Global Devic's Disease Drug Revenue by Type (2021-2026) & (K Tons) Table 26. Global Devic's Disease Drug Revenue by Type (2027-2032) & (K Tons) Table 27. Global Devic's Disease Drug Revenue Market Share by Type (2021-2026) Table 28. Global Devic's Disease Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Others Table 32. Global Devic's Disease Drug Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 33. Global Devic's Disease Drug Sales by Application (2021-2026) & (K Tons) Table 34. Global Devic's Disease Drug Sales by Application (2027-2032) & (K Tons) Table 35. Global Devic's Disease Drug Sales Market Share by Application (2021-2026) Table 36. Global Devic's Disease Drug Sales Market Share by Application (2027-2032) Table 37. Global Devic's Disease Drug Revenue by Application 2021 VS 2025 VS 2032 (K Tons) Table 38. Global Devic's Disease Drug Revenue by Application (2021-2026) & (K Tons) Table 39. Global Devic's Disease Drug Revenue by Application (2027-2032) & (K Tons) Table 40. Global Devic's Disease Drug Revenue Market Share by Application (2021-2026) Table 41. Global Devic's Disease Drug Revenue Market Share by Application (2027-2032) Table 42. Global Devic's Disease Drug Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 43. Global Devic's Disease Drug Sales by Region (2021-2026) & (K Tons) Table 44. Global Devic's Disease Drug Sales Market Share by Region (2021-2026) Table 45. Global Devic's Disease Drug Sales Forecasted by Region (2027-2032) & (K Tons) Table 46. Global Devic's Disease Drug Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Devic's Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 48. North America Devic's Disease Drug Sales by Country (2021-2026) & (K Tons) Table 49. North America Devic's Disease Drug Sales by Country (2027-2032) & (K Tons) Table 50. Europe Devic's Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 51. Europe Devic's Disease Drug Sales by Country (2021-2026) & (K Tons) Table 52. Europe Devic's Disease Drug Sales by Country (2027-2032) & (K Tons) Table 53. Asia Pacific Devic's Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 54. Asia Pacific Devic's Disease Drug Sales by Country (2021-2026) & (K Tons) Table 55. Asia Pacific Devic's Disease Drug Sales by Country (2027-2032) & (K Tons) Table 56. South America, Middle East and Africa Devic's Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 57. South America, Middle East and Africa Devic's Disease Drug Sales by Country (2021-2026) & (K Tons) Table 58. South America, Middle East and Africa Devic's Disease Drug Sales by Country (2027-2032) & (K Tons) Table 59. Global Devic's Disease Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Devic's Disease Drug Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Devic's Disease Drug Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Devic's Disease Drug Revenue Market Share by Region (2021-2026) Table 63. Global Devic's Disease Drug Revenue Market Share by Region (2027-2032) Table 64. CBOP Company Information Table 65. CBOP Business Overview Table 66. CBOP Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. CBOP Devic's Disease Drug Product Portfolio Table 68. CBOP Recent Development Table 69. CSL Company Information Table 70. CSL Business Overview Table 71. CSL Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. CSL Devic's Disease Drug Product Portfolio Table 73. CSL Recent Development Table 74. Fresenius Company Information Table 75. Fresenius Business Overview Table 76. Fresenius Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Fresenius Devic's Disease Drug Product Portfolio Table 78. Fresenius Recent Development Table 79. Grifols Company Information Table 80. Grifols Business Overview Table 81. Grifols Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Grifols Devic's Disease Drug Product Portfolio Table 83. Grifols Recent Development Table 84. Gyjtrs Company Information Table 85. Gyjtrs Business Overview Table 86. Gyjtrs Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Gyjtrs Devic's Disease Drug Product Portfolio Table 88. Gyjtrs Recent Development Table 89. Intas Company Information Table 90. Intas Business Overview Table 91. Intas Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Intas Devic's Disease Drug Product Portfolio Table 93. Intas Recent Development Table 94. Nang Kuang Company Information Table 95. Nang Kuang Business Overview Table 96. Nang Kuang Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Nang Kuang Devic's Disease Drug Product Portfolio Table 98. Nang Kuang Recent Development Table 99. Octapharma Company Information Table 100. Octapharma Business Overview Table 101. Octapharma Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Octapharma Devic's Disease Drug Product Portfolio Table 103. Octapharma Recent Development Table 104. Tianjin Kingyork Company Information Table 105. Tianjin Kingyork Business Overview Table 106. Tianjin Kingyork Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Tianjin Kingyork Devic's Disease Drug Product Portfolio Table 108. Tianjin Kingyork Recent Development Table 109. Baxter Company Information Table 110. Baxter Business Overview Table 111. Baxter Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Baxter Devic's Disease Drug Product Portfolio Table 113. Baxter Recent Development Table 114. Pfizer Company Information Table 115. Pfizer Business Overview Table 116. Pfizer Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Pfizer Devic's Disease Drug Product Portfolio Table 118. Pfizer Recent Development Table 119. Sandoz Company Information Table 120. Sandoz Business Overview Table 121. Sandoz Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Sandoz Devic's Disease Drug Product Portfolio Table 123. Sandoz Recent Development Table 124. TEVA Company Information Table 125. TEVA Business Overview Table 126. TEVA Devic's Disease Drug Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. TEVA Devic's Disease Drug Product Portfolio Table 128. TEVA Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Devic's Disease Drug Distributors List Table 132. Devic's Disease Drug Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Devic's Disease Drug Product Image Figure 2. Global Devic's Disease Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Devic's Disease Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Devic's Disease Drug Sales (2021-2032) & (K Tons) Figure 5. Global Devic's Disease Drug Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Devic's Disease Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Glucocorticoids Image Figure 9. Immunoglobulin Image Figure 10. Other Image Figure 11. Global Devic's Disease Drug Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 12. Global Devic's Disease Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Devic's Disease Drug Sales Market Share by Type (2021-2032) Figure 14. Global Devic's Disease Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 15. Global Devic's Disease Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Devic's Disease Drug Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Devic's Disease Drug Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 21. Global Devic's Disease Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Devic's Disease Drug Sales Market Share by Application (2021-2032) Figure 23. Global Devic's Disease Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 24. Global Devic's Disease Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Devic's Disease Drug Revenue Market Share by Application (2021-2032) Figure 26. North America Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 27. North America Devic's Disease Drug Sales Market Share by Country (2021-2032) Figure 28. U.S. Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 29. Canada Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 30. Mexico Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 31. Europe Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 32. Europe Devic's Disease Drug Sales Market Share by Country (2021-2032) Figure 33. Germany Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 34. France Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 35. U.K. Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 36. Italy Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 37. Netherlands Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 38. Asia Pacific Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 39. Asia Pacific Devic's Disease Drug Sales Market Share by Country (2021-2032) Figure 40. China Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 41. Japan Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 42. South Korea Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 43. Southeast Asia Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 44. India Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 45. Australia Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 46. South America, Middle East and Africa Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 47. South America, Middle East and Africa Devic's Disease Drug Sales Market Share by Country (2021-2032) Figure 48. Brazil Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 49. South Africa Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 50. Saudi Arabia Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 51. Turkey Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 52. Argentina Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 53. UAE Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 54. Egypt Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 55. Chile Devic's Disease Drug Sales and Growth Rate (2021-2032) & (K Tons) Figure 56. Global Devic's Disease Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Devic's Disease Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Devic's Disease Drug Revenue (2021-2032) & (US$ Million) Figure 59. North America Devic's Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Devic's Disease Drug Revenue (2021-2032) & (US$ Million) Figure 61. Europe Devic's Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Devic's Disease Drug Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Devic's Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Devic's Disease Drug Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Devic's Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Devic's Disease Drug Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Devic's Disease Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Glucocorticoids
  • Immunoglobulin
  • Other
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • CBOP
  • CSL
  • Fresenius
  • Grifols
  • Gyjtrs
  • Intas
  • Nang Kuang
  • Octapharma
  • Tianjin Kingyork
  • Baxter
  • Pfizer
  • Sandoz
  • TEVA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Devic's Disease Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Devic's Disease Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Devic's Disease Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Devic's Disease Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Devic's Disease Drug Market Dynamics
  1. 2.1 Devic's Disease Drug Industry Trends
  2. 2.2 Devic's Disease Drug Industry Drivers
  3. 2.3 Devic's Disease Drug Industry Opportunities and Challenges
  4. 2.4 Devic's Disease Drug Industry Restraints
3 Devic's Disease Drug Market by Manufacturers
  1. 3.1 Global Devic's Disease Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Devic's Disease Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Devic's Disease Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Devic's Disease Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Devic's Disease Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Devic's Disease Drug Manufacturers, Product Type & Application
  7. 3.7 Global Devic's Disease Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Devic's Disease Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Devic's Disease Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Devic's Disease Drug Tier 1, Tier 2, and Tier 3
4 Devic's Disease Drug Market by Type
  1. 4.1 Devic's Disease Drug Type Introduction
  2. 4.1.1 Glucocorticoids
  3. 4.1.2 Immunoglobulin
  4. 4.1.3 Other
  5. 4.2 Global Devic's Disease Drug Sales by Type
  6. 4.2.1 Global Devic's Disease Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Devic's Disease Drug Sales by Type (2021-2032)
  8. 4.2.3 Global Devic's Disease Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global Devic's Disease Drug Revenue by Type
  10. 4.3.1 Global Devic's Disease Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Devic's Disease Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global Devic's Disease Drug Revenue Market Share by Type (2021-2032)
5 Devic's Disease Drug Market by Application
  1. 5.1 Devic's Disease Drug Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Devic's Disease Drug Sales by Application
  6. 5.2.1 Global Devic's Disease Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Devic's Disease Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Devic's Disease Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Devic's Disease Drug Revenue by Application
  10. 5.3.1 Global Devic's Disease Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Devic's Disease Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Devic's Disease Drug Revenue Market Share by Application (2021-2032)
6 Global Devic's Disease Drug Sales by Region
  1. 6.1 Global Devic's Disease Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Devic's Disease Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Devic's Disease Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Devic's Disease Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Devic's Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Devic's Disease Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Devic's Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Devic's Disease Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Devic's Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Devic's Disease Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Devic's Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Devic's Disease Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Devic's Disease Drug Revenue by Region
  1. 7.1 Global Devic's Disease Drug Revenue by Region
  2. 7.1.1 Global Devic's Disease Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Devic's Disease Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Devic's Disease Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Devic's Disease Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Devic's Disease Drug Revenue (2021-2032)
  8. 7.2.2 North America Devic's Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Devic's Disease Drug Revenue (2021-2032)
  11. 7.3.2 Europe Devic's Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Devic's Disease Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Devic's Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Devic's Disease Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Devic's Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CBOP
  2. 8.1.1 CBOP Company Information
  3. 8.1.2 CBOP Business Overview
  4. 8.1.3 CBOP Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CBOP Devic's Disease Drug Product Portfolio
  6. 8.1.5 CBOP Recent Developments
  7. 8.2 CSL
  8. 8.2.1 CSL Company Information
  9. 8.2.2 CSL Business Overview
  10. 8.2.3 CSL Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CSL Devic's Disease Drug Product Portfolio
  12. 8.2.5 CSL Recent Developments
  13. 8.3 Fresenius
  14. 8.3.1 Fresenius Company Information
  15. 8.3.2 Fresenius Business Overview
  16. 8.3.3 Fresenius Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Devic's Disease Drug Product Portfolio
  18. 8.3.5 Fresenius Recent Developments
  19. 8.4 Grifols
  20. 8.4.1 Grifols Company Information
  21. 8.4.2 Grifols Business Overview
  22. 8.4.3 Grifols Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Grifols Devic's Disease Drug Product Portfolio
  24. 8.4.5 Grifols Recent Developments
  25. 8.5 Gyjtrs
  26. 8.5.1 Gyjtrs Company Information
  27. 8.5.2 Gyjtrs Business Overview
  28. 8.5.3 Gyjtrs Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Gyjtrs Devic's Disease Drug Product Portfolio
  30. 8.5.5 Gyjtrs Recent Developments
  31. 8.6 Intas
  32. 8.6.1 Intas Company Information
  33. 8.6.2 Intas Business Overview
  34. 8.6.3 Intas Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Intas Devic's Disease Drug Product Portfolio
  36. 8.6.5 Intas Recent Developments
  37. 8.7 Nang Kuang
  38. 8.7.1 Nang Kuang Company Information
  39. 8.7.2 Nang Kuang Business Overview
  40. 8.7.3 Nang Kuang Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nang Kuang Devic's Disease Drug Product Portfolio
  42. 8.7.5 Nang Kuang Recent Developments
  43. 8.8 Octapharma
  44. 8.8.1 Octapharma Company Information
  45. 8.8.2 Octapharma Business Overview
  46. 8.8.3 Octapharma Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Octapharma Devic's Disease Drug Product Portfolio
  48. 8.8.5 Octapharma Recent Developments
  49. 8.9 Tianjin Kingyork
  50. 8.9.1 Tianjin Kingyork Company Information
  51. 8.9.2 Tianjin Kingyork Business Overview
  52. 8.9.3 Tianjin Kingyork Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Tianjin Kingyork Devic's Disease Drug Product Portfolio
  54. 8.9.5 Tianjin Kingyork Recent Developments
  55. 8.10 Baxter
  56. 8.10.1 Baxter Company Information
  57. 8.10.2 Baxter Business Overview
  58. 8.10.3 Baxter Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Baxter Devic's Disease Drug Product Portfolio
  60. 8.10.5 Baxter Recent Developments
  61. 8.11 Pfizer
  62. 8.11.1 Pfizer Company Information
  63. 8.11.2 Pfizer Business Overview
  64. 8.11.3 Pfizer Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pfizer Devic's Disease Drug Product Portfolio
  66. 8.11.5 Pfizer Recent Developments
  67. 8.12 Sandoz
  68. 8.12.1 Sandoz Company Information
  69. 8.12.2 Sandoz Business Overview
  70. 8.12.3 Sandoz Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sandoz Devic's Disease Drug Product Portfolio
  72. 8.12.5 Sandoz Recent Developments
  73. 8.13 TEVA
  74. 8.13.1 TEVA Company Information
  75. 8.13.2 TEVA Business Overview
  76. 8.13.3 TEVA Devic's Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 TEVA Devic's Disease Drug Product Portfolio
  78. 8.13.5 TEVA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Devic's Disease Drug Value Chain Analysis
  2. 9.1.1 Devic's Disease Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Devic's Disease Drug Production Mode & Process
  6. 9.2 Devic's Disease Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Devic's Disease Drug Distributors
  9. 9.2.3 Devic's Disease Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst